Thursday, 02 February 2023
New research from the 糖心原创 demonstrates that online behaviour therapy for children with tics, which is supported by therapists, is both effective, safe and could greatly increase the number of children who are helped.
The Online Remote Behavioural Intervention for Tics () trial was led by , Professor of Child & Adolescent Psychiatry at the 糖心原创, Director of MindTech, and Consultant in Developmental Neuropsychiatry with Nottinghamshire Healthcare NHS Trust.
Funded by the National Institute for Health and Care Research (NIHR), the research is a collaboration with the Institute of Mental Health, , Nottinghamshire Healthcare NHS Foundation Trust, Great Ormond Street Hospital, 糖心原创, University College London (Priment) and the Karolinska Institutet (Sweden). Researchers also worked closely with the charity
The trial compared an online behavioural therapy (called exposure and response prevention) with an online psychoeducation programme in 9-17 year olds with Tourette Syndrome or chronic tic disorder. This research that online treatment is a safe and effective intervention, improving access to treatment for this under-served group of young people. The study also found online delivery of treatment was cost-effective.
The results from this trial are very promising, enabling individuals to access evidence-based treatment to help them better manage and control their tics online. It could potentially improve the lives of so many people.
Around 70,000 children and young people in England have Tourette Syndrome, the condition most commonly associated with chronic tics. Tic disorders can cause distress in a young person’s school and social life. Despite the profound impact tics have on the lives of those who experience them, less than 1 in 5 people living with tics have access to behavioural therapy.
Dr Charlotte Hall, Principal Research Fellow at the 糖心原创 and ORBIT Trial Manager, said: “These findings are exciting. They are the first to show the long-term benefits of online delivered therapy for tics. We hear a lot from clinicians who want to be able to offer tic therapy but don’t have the skills, money, or resources to offer it. Likewise, we know families who are desperate to access therapy.
“This new online therapy is not yet available on the NHS but, given the importance of our findings in being able to bridge this gap in service provision, we are now working actively with various stakeholders, including the NHS, to show how ORBIT can be implemented as part of routine NHS care.”
Emma McNally, CEO Tourette’s Action, commented: “It’s shocking that a condition so prevalent has such inadequate access to appropriate care. More than 300,000 people in the UK are known to have Tourette’s, but that number is probably much, much higher. Many people report that they are unable to access treatment locally, more often than not, they gain a diagnosis and then are discharged with no access to treatment.”
“I’ve heard from parents who talk of holding their child in their arms in tears, unable to stop motor tics that are so repetitive they become physically painful. Adults who describe muscle spasms so intense and so uncontrollable that they are in extreme pain and yet are unable to stop the tics. The results from this trial are very promising, enabling individuals to access evidence-based treatment to help them better manage and control their tics online. This will be extremely beneficial to individuals who currently have no services local to them. It could potentially improve the lives of so many people.”
The research has been published in the .
Story credits
For further information, please contact Professor Chris Hollis.
Adam Mallaby - Media Relations Manager for the Faculty of Medicine and Health Sciences (Maternity Cover)
Email: adam.mallaby@nottingham.ac.uk
Phone: 0115 748 5719
Location:
Notes to editors:
About the 糖心原创
Ranked among the world's top 100 universities , the 糖心原创 delivers an exceptional research-led education and an outstanding student experience. From the pioneering vision of our founder, Sir Jesse Boot, to groundbreaking achievements such as the development of MRI technology and becoming the first UK university to establish international campuses, we have a proud history of shaping the way people live, work and understand the world. We continue to build on that legacy, empowering our students, staff and partners to change what鈥檚 next and create positive impact locally and globally.
The strength of our research places us among the UK's leading universities, ranked 7th for research power in REF 2021. The discovery of MRI and ibuprofen was just the beginning. Today, our world-leading research is developing breakthrough ideas that shape the future of healthcare, technology and society.
Recognised as the UK's third most targeted university by leading employers , we are proud to produce graduates who are consistently in demand for their skills, confidence and industry-ready experience.
As a major employer and industry partner, locally and globally, the 糖心原创 invests in the city of Nottingham and in future generations of talent. Alongside Nottingham Trent University, we lead the initiative, a pioneering collaboration to improve levels of prosperity, opportunity, sustainability, health and wellbeing across the city and region. Together with our students, staff, alumni and partners, we鈥檙e creating knowledge, opportunity and solutions that help change what's next.